|
Volumn 125, Issue 4, 2010, Pages
|
Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ALEMTUZUMAB;
AZATHIOPRINE;
BUSULFAN;
CYCLOSPORIN;
FLUDARABINE;
INFLIXIMAB;
MESALAZINE;
METHOTREXATE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PROTEIN P47;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
STEROID;
THALIDOMIDE;
ADOLESCENT;
ANUS FISSURE;
APHTHOUS STOMATITIS;
BEHCET DISEASE;
BLOODY DIARRHEA;
CHILD;
CHRONIC GRANULOMATOUS DISEASE;
CLINICAL ARTICLE;
CROHN DISEASE;
ECZEMA;
ENTERITIS;
ENZYME ACTIVITY;
FEMALE;
FISTULA;
FLUORESCENCE IN SITU HYBRIDIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
INFANT;
JUVENILE RHEUMATOID ARTHRITIS;
LETTER;
MALE;
PERIANAL ABSCESS;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PYODERMA GANGRENOSUM;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
|
EID: 77950359402
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaci.2010.01.035 Document Type: Letter |
Times cited : (39)
|
References (8)
|